|
|
|
Download Adobe Acrobat Reader
- to read / print PDF files
|
May/June 2008
Medication Administration Through
Enteral Feeding Tubes
(PDF file 112 KB)
Marcia Wyman, Pharm.D.
|
March/April 2008
Prevention of Infective Endocarditis: 2007 Guidelines from the American Heart Association (AHA)
(PDF file 121 KB)
Sharon Sam, Pharm.D.
|
January/February 2008
Intravenous Immune Globulin (IVIG): A Review of Formulary Restrictions
(PDF file 106 KB)
|
November/December 2007
Update: Erythropoiesis-Stimulating Agents, Part II
(PDF file 109 KB)
Ambar Khan, Pharm.D., BCOP
|
September/October 2007
Update: Erythropoiesis-Stimulating Agents, Part I
(PDF file 122 KB)
Amy T. Sekel, Pharm.D.
|
July/August 2007
NovoSeven®: Cleveland Clinic Guidelines
(PDF file 145 KB)
Pam Risko, Pharm.D.
|
May/June 2007
Aliskiren (Tekturna®) for Hypertension
(PDF file 136 KB)
Kelli Branch, Pharm.D. Candidate
|
March/April 2007
Ceprotin™ FDA-Approved for Treatment of Rare Clotting Disorder
(PDF file 121 KB)
Abby E. Kusnerik, Pharm.D. Candidate
|
January/February 2007
Use of Inhaled Human Insulin in Patients with Diabetes Mellitus
(PDF file 167 KB)
Linda Ghobrial, Pharm.D.
|
November/December 2006
Prophylaxis Against Human Papillomavirus Infections with Gardasil® Vaccine(PDF file 132 KB)
Jaime Anderson, Pharm.D.
|
September/October 2006
Osteonecrosis of the Jaw Associated with the
Use of Bisphosphonates: Part II(PDF file 208 KB)
Kathryn B. Nguyen, Pharm.D.
|
July/August 2006
Osteonecrosis of the Jaw Associated with the
Use of Bisphosphonates: Part I (PDF file 180 KB)
Kathryn B. Nguyen, Pharm.D.
|
May/June 2006
Medications Used
for Smoking Cessation (PDF file 317 KB)
Mandy Leonard, Pharm.D., BCPS
|
March/April 2006
2005 Changes to the American
Heart Association Guidelines for Cardiopulmonary Resuscitation
(PDF file 148 KB)
Heather Bockheim, Pharm.D.
|
January/February 2006
Pharmocogenomics
(PDF file 1.33 MB)
Jessica Dusky, Pharm.D. Candidate
|
November/December 2005
Pregabalin
(Lyrica®): Part II(PDF file 326 KB)
Chadrick Lowther, Pharm.D.
|
September/October 2005
Pregabalin
(Lyrica®): Part I
Chadrick Lowther, Pharm.D.
|
July/August 2005
Prevention
of Meningococcal Disease
Phil Chung, Pharm.D.
|
May/June 2005
The Cleveland
Clinic Foundation's Recommendations for Cyclooxygenase-2 Inhibitor
Use
Meghan K. Lehmann, Pharm.D.
|
March/April 2005
New
Therapies for the Treatment of Overactive Bladder
Abigail Bridger, Pharm.D.
|
January/February 2005
Emerging Therapies
in the Treatment of Type 2 Diabetes
Marc A. Earl, Pharm.D.
|
November/December 2004
Fosphenytoin
(Cerebyx®)
Tyrone Lin, Pharm.D.
Did You Know...
Acamprosate calcium (Campral®)
|
September/October 2004
Duloxetine
(Cymbalta®)
Ian Hollis, Pharm.D Candidate
Did You Know....
New Formulations of Fenofibrate for the Treatment of Primary Hypercholesterolemia
or Mixed Dyslipidemia
|
July/August 2004
Daptomycin
(Cubicin™): A New Treatment Option for Gram-Positive Infections
Amy Hirsch, Pharm.D.
The Cleveland
Clinic Foundation Pharmacy and Therapeutics Committee Automatic
Therapeutic Interchange Program Epoetin alfa (Procrit®) to
Darbepoetin alfa (Aranesp™)
AB-Rated Oral Contraceptives
|
May/June 2004
Namenda™
(Memantine) for Moderate-to-Severe Alzheimer's Disease
Shannon Just, Pharm.D.
Spiriva®
HandiHaler® (Tiotropium) - A New Therapy for COPD
Katie Milner, Pharm.D.
|
March/April 2004
New Competition
for Viagra®
Christina Collins, Pharm.D. Candidate
Seasonale®
(levonorgestrel 0.15 mg/ethinyl estradiol 0.03 mg) Extended-Cycle
Oral Contraception
Amy Decker, Pharm.D. Candidate
|
January/February 2004
Omalizumab:
A New Treatment for the Management of Asthma
Bridgette L. Sims, Pharm.D. Candidate
|
November/December 2003
Rosuvastatin:
A New Pharmacotherapy for LDL-Cholesterol Reduction
Katie E. Meister, Pharm.D.
|
September/October 2003
Intravenous
Pantoprazole (Protonix®)
Jeffrey Bruno, Pharm.D.
|
July/August 2003
New Antifungal
Agents: Additions to the Existing Armamentarium (Part 2)
Jennifer Long, Pharm.D., BCPS
|
May/June 2003
New Antifungal
Agents: Additions to the Existing Armamentarium (Part I)
Jennifer Long, Pharm.D., BCPS
|
March/April 2003
The Safety
of Ephedra and Related Alkaloids
Amy Dickson, Pharm.D. Candidate
Ezetimibe
(Zetia™)
Bernadette A. Clark, Pharm.D. Candidate
|
January/February 2003
Ziprasidone
Mesylate Injection
Marcia Wyman, Pharm.D.
Dietary
Supplements Update: Seals-of-Approval
Enoxaparin
Clinical Pearl
Jeff Ketz, Pharm.D., BCPS
|
November/December 2002
5-HT3 Receptor
Antagonists and ECG Effects
Mandy C. Leonard, Pharm.D., BCPS and Michael A. Militello,
Pharm.D., BCPS
|
September/October 2002
Ginkgo Biloba
and Memory
Andreea Popa, Pharm.D.
|
July/August 2002
A Review
of Coagulation Products Used in the Treatment of Hemophilia
Nadine Chehab, Pharm.D.
Irritable Bowel
Syndrome: Two Drug Options
|
March/April 2002
Bosentan (Tracleer™),
a New Agent for the Treatment of Pulmonary Arterial Hypertension
Andreea Popa, Pharm.D. Candidate
|
January/February 2002
Drotrecogin
alfa-Recombinant Human Activated Protein C (Xigris™)
Jeffrey P. Gonzales, Pharm.D.
|
November/December 2001
New Oral
Antiepileptic Agents
Rhonda Rhea, Pharm.D.
Drug
Shortages
|
September/October 2001
Type
II Heparin-Induced Thrombocytopenia: New Treatment Options
Robert Barcelona, Pharm.D.
|
July/August 2001
Esomeprazole
(Nexium™): A New Proton Pump Inhibitor
Mandy Leonard, Pharm.D., BCPS
Galantamine:
Did You Know?
|
May/June 2001
A
Review of Oral Antidiabetic Agents
Jeff Ketz, Pharm.D., BCPS
Ziprasidone:
Did You Know?
Medication
Safety Alert: Advair™Diskus®
|
March/April 2001
Interactions
Between Herbs and Cardiac Medications
Mandy C. Leonard, Pharm.D., BCPS
Nateglinide
(Starlix®)
|
January/February 2001
Tenecteplase
(TNKase™): A Clinical Review
Michael Militello, Pharm.D., BCPS
Allergic
Reactions to Local Anesthetics
|
November/December 2000
Concerta™
for Attention-Deficit/Hyperactivity Disorder
Margaret Peters, Pharm.D.
Glucovance™,
a combination oral antihyperglycemic agent, wins FDA approval
Kristina Pascuzzi, Pharm.D. student
|
September/October 2000
Dofetilde: A
New Class III Antiarrhythmic
Jodie Zalewski, Pharm.D.
Submitting
Research Protocols to the Institutional Review Board
Kenneth Shermock, Pharm.D.
|
July/August 2000
New FDA-Approved
Indications for Risedronate
Marcia Wyman, Pharm.D. Candidate
|
May/June 2000
Cisapride
Withdrawal Requires Alternative Therapy
Jodie M. Zalewski, Pharm.D.
Alosetron:
A New Agent for the Treatment of Irritable Bowel Syndrome
|
November/December 1999
The General Use
of Medications in Pregnancy
Christina H. Stack, R. Ph., Pharm.D. Candidate
|
